The abstract is read at the publisher; the summary is JClub's.
TRIM31 aggravates cerebral ischemic injury by inhibiting autophagosome–lysosome fusion through promoting TLR9 degradation, linked to impaired autophagic flux in stroke models.
- Why it matters: Neuronal damage after stroke is linked to dysfunction of the autophagy–lysosome system, but how this pathway is regulated remains unclear.
- What they did: In stroke models, TLR9 was upregulated and supported autophagosome–lysosome fusion; TRIM31 interacted with TLR9, drove k48-linked polyubiquitination, and enabled proteasome-dependent degradation.
- The result: By negatively regulating TLR9, TRIM31 impaired autophagosome–lysosome fusion during cerebral ischemic injury, suggesting that enhancing fusion via TLR9 could be therapeutic.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.